AlpInvest Partners’s Pacira BioSciences PCRX Stock Holding History

AlpInvest Partners’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-7,996	Closed	-$735K	–	25
2014 Q2	$735K	Sell	7,996 -35,600	-82%	-$2.71M	2.62%	11
2014 Q1	$3.05M	Sell	43,596 -26,140	-37%	-$1.78M	7.04%	4
2013 Q4	$4.01M	Sell	69,736 -10,264	-13%	-$540K	6.51%	5
2013 Q3	$3.85M	Sell	80,000 -11,700	-13%	-$426K	3.04%	9
2013 Q2	$2.66M	Buy	+91,700	New	+$2.65M	2.53%	10

Other funds holding PCRX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AlpInvest Partners's PCRX Position: Q3 2014 in Review

AlpInvest Partners sold out of Pacira BioSciences (PCRX) in Q3 2014, closing a stake of 7,996 shares — an estimated $735K sold.

AlpInvest Partners first reported a position in PCRX in Q2 2013 and held it in 5 quarters. The position peaked at $4.01M in Q4 2013. 208 funds tracked by Wall St. Rank hold PCRX as of Q3 2014.

AlpInvest Partners reported no remaining Pacira BioSciences position as of Q3 2014 after selling out during the quarter.
AlpInvest Partners sold 7,996 Pacira BioSciences shares in Q3 2014, an estimated $735K.
AlpInvest Partners first reported a position in Pacira BioSciences in Q2 2013 and held it in 5 quarters.
AlpInvest Partners's Pacira BioSciences position peaked at $4.01M in Q4 2013.
208 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2014.

Based on AlpInvest Partners's 13F filing for Q3 2014, filed 14 Nov 2014.